SENORES PHARMACEUTICALS Financial Statement Analysis
|
||
|
The Revenues of SENORES PHARMACEUTICALS have increased by 85.65% YoY .
The Earnings Per Share (EPS) of SENORES PHARMACEUTICALS has increased by 23.38 % YoY. |
||
SENORES PHARMACEUTICALS Last 5 Annual Financial Results
[BOM: 544319|NSE : SENORES]
| Consolidated | Mar2025 | Mar2024 | Mar2023 | Mar2022 |
|---|---|---|---|---|
| Revenues | ₹398 Cr | ₹215 Cr | ₹35 Cr | ₹14 Cr |
| Expenses | ₹309 Cr | ₹173 Cr | ₹23 Cr | ₹12 Cr |
| Operating Profit (Excl OI) | ₹90 Cr | ₹42 Cr | ₹13 Cr | ₹1.95 Cr |
| Other Income | ₹19 Cr | ₹2.82 Cr | ₹3.68 Cr | ₹0.46 Cr |
| Interest | ₹22 Cr | ₹9.45 Cr | ₹2.14 Cr | ₹0.57 Cr |
| Depreciation | ₹17 Cr | ₹10.00 Cr | ₹1.78 Cr | ₹0.71 Cr |
| Profit Before Tax | ₹71 Cr | ₹25 Cr | ₹12 Cr | ₹1.14 Cr |
| Profit After Tax | ₹58 Cr | ₹33 Cr | ₹8.43 Cr | ₹0.99 Cr |
| Consolidated Net Profit | ₹59 Cr | ₹31 Cr | ₹8.43 Cr | ₹0.99 Cr |
| Earnings Per Share (Rs) | ₹12.72 | ₹10.31 | ₹8.59 | ₹1.13 |
| PAT Margin (%) | 14.65 | 15.25 | 23.86 | 6.99 |
| ROE(%) | 11.78 | 26.19 | 20.55 | 2.71 |
| ROCE(%) | 11.94 | 12.31 | 18.56 | 3.36 |
| Total Debt/Equity(x) | 0.39 | 1.22 | 1.34 | 0.39 |
Key Financials |
||
| Market Cap | : | ₹ 6,433.9 Cr |
| Revenue (TTM) | : | ₹ 649.5 Cr |
| Net Profit(TTM) | : | ₹ 121.6 Cr |
| EPS (TTM) | : | ₹ 26.4 |
| P/E (TTM) | : | 52.9 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| SENORES PHARMACEUTICALS | -0.3% | 8.4% | 125.8% |
| SUN PHARMACEUTICAL INDUSTRIES | 1.1% | 4.6% | 14.2% |
| DIVIS LABORATORIES | 0.6% | 8.3% | 8.2% |
| TORRENT PHARMACEUTICALS | 6.3% | 12.2% | 45.5% |
| CIPLA | -1.7% | -2.8% | -4% |
| DR REDDYS LABORATORIES | -3.7% | -10.4% | -6% |
| MANKIND PHARMA | 2.6% | 1.1% | -3% |
| LUPIN | -1.9% | 1.7% | 24.7% |
| ZYDUS LIFESCIENCES | -2.6% | 0.1% | 16.6% |
SENORES PHARMACEUTICALS Revenues
[BOM: 544319|NSE : SENORES]
| Y-o-Y | 85.65 % |
| 5 Yr CAGR | 204.04 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2025 | ₹398 Cr | 85.65 | |
| Mar2024 | ₹215 Cr | 507.07 | |
| Mar2023 | ₹35 Cr | 149.38 | |
| Mar2022 | ₹14 Cr | - | |
SENORES PHARMACEUTICALS Operating Profit
[BOM: 544319|NSE : SENORES]
| Y-o-Y | 115.61 % |
| 5 Yr CAGR | 258.09 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹90 Cr | 115.61 | |
| Mar2024 | ₹42 Cr | 228.10 | |
| Mar2023 | ₹13 Cr | 549.08 | |
| Mar2022 | ₹1.95 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | 16.15 % |
| 5 Yr CAGR | 17.77 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2025 | 22.51% | 16.15 | |
| Mar2024 | 19.38% | -45.94 | |
| Mar2023 | 35.85% | 160.16 | |
| Mar2022 | 13.78% | - | |
SENORES PHARMACEUTICALS Profit After Tax
[BOM: 544319|NSE : SENORES]
| Y-o-Y | 86.14 % |
| 5 Yr CAGR | 289.50 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2025 | ₹59 Cr | 86.14 | |
| Mar2024 | ₹31 Cr | 273.06 | |
| Mar2023 | ₹8.43 Cr | 750.96 | |
| Mar2022 | ₹0.99 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | -3.93 % |
| 5 Yr CAGR | 27.97 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2025 | 14.65 % | -3.93 | |
| Mar2024 | 15.25 % | -36.09 | |
| Mar2023 | 23.86 % | 241.34 | |
| Mar2022 | 6.99 % | - | |
SENORES PHARMACEUTICALS Earnings Per Share (EPS)
[BOM: 544319|NSE : SENORES]
| Y-o-Y | 23.38 % |
| 5 Yr CAGR | 124.11 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2025 | ₹13 | 23.38 | |
| Mar2024 | ₹10 | 20.02 | |
| Mar2023 | ₹8.59 | 660.18 | |
| Mar2022 | ₹1.13 | - | |
SENORES PHARMACEUTICALS Return on Capital Employed (ROCE)
[BOM: 544319|NSE : SENORES]
| Y-o-Y | -3.01 % |
| 5 Yr CAGR | 52.60 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2025 | 11.94% | -3.01 | |
| Mar2024 | 12.31% | -33.67 | |
| Mar2023 | 18.56% | 452.38 | |
| Mar2022 | 3.36% | - | |
SENORES PHARMACEUTICALS Share Price vs Sensex
| Current Share Price | : | ₹1,395.7 |
| Current MarketCap | : | ₹ 6,433.9 Cr |
| Updated EOD on | : | Jul 23,2026 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SENORES PHARMACEUTICALS | -0.3% |
8.4% |
125.8% |
| SENSEX | -1% |
-0.9% |
-7.5% |
SENORES PHARMACEUTICALS related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| BSE HEALTHCARE | -1.7% | 2.8% | 9.3% |
No NSE index found
You may also like the below Video Courses
FAQ about SENORES PHARMACEUTICALS Financials
How the annual revenues of SENORES PHARMACEUTICALS have changed ?
The Revenues of SENORES PHARMACEUTICALS have increased by 85.65% YoY .
How the Earnings per Share (EPS) of SENORES PHARMACEUTICALS have changed?
The Earnings Per Share (EPS) of SENORES PHARMACEUTICALS has increased by 23.38 % YoY .
Check out Intrinsic Value of Peers of SENORES PHARMACEUTICALS
Compare Stock Analytics of Peers of SENORES PHARMACEUTICALS
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs TORRENT PHARMACEUTICALS LTD
CIPLA LTD vs DR REDDYS LABORATORIES LTD vs
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs TORRENT PHARMACEUTICALS LTD
CIPLA LTD vs DR REDDYS LABORATORIES LTD vs
